Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Ying B, Darling TL, Desai P, Liang CY, Dmitriev IP, Soudani N, Bricker T, Kashentseva EA, Harastani H, Raju S, Liu M, Schmidt AG, Curiel DT, Boon ACM, Diamond MS.
Ying B, et al. Among authors: bricker t.
Nat Immunol. 2024 Mar;25(3):537-551. doi: 10.1038/s41590-024-01743-x. Epub 2024 Feb 9.
Nat Immunol. 2024.
PMID: 38337035
Free PMC article.